Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
07/26/2012 | US20120189542 Anti-CD19 Antibodies |
07/26/2012 | US20120189537 Nitrile derivatives and their pharmaceutical use and compositions |
07/26/2012 | DE102010036997A1 LOV-Domänen Protein zur photosensiblen Desfunktionalisierung LOV domain protein for photosensitive Desfunktionalisierung |
07/26/2012 | CA2825382A1 Agent for the treatment of alopecia |
07/26/2012 | CA2825273A1 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
07/26/2012 | CA2824791A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
07/26/2012 | CA2824689A1 Combination therapy for cancer |
07/26/2012 | CA2824515A1 Compositions and methods for modulating gamma-c-cytokine activity |
07/26/2012 | CA2824397A1 Combination of acylated glucagon analogues with insulin analogues |
07/26/2012 | CA2823712A1 Apolipoprotein aiv as an antidiabetic peptide |
07/26/2012 | CA2823705A1 Wound healing device and method |
07/26/2012 | CA2822530A1 Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles |
07/25/2012 | EP2479290A2 Methods for the administration of iloperidone |
07/25/2012 | EP2479276A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
07/25/2012 | EP2479275A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same |
07/25/2012 | EP2479193A1 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
07/25/2012 | EP2479192A1 Compositions and Methods for Diagnosing and Treating Cancer |
07/25/2012 | EP2478923A1 Bone regeneration agent including gelatin |
07/25/2012 | EP2478914A1 Modified erythropoietin to which water-soluble long-chain molecule is added |
07/25/2012 | EP2478913A1 Synthetic HLA binding peptide analogues and uses thereof |
07/25/2012 | EP2478912A1 Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy |
07/25/2012 | EP2478898A1 Method of regulating fertilizing ability using cyclic ADP-ribose and CD38 |
07/25/2012 | EP2478779A1 Composition for providing beneficial health effects |
07/25/2012 | EP2478766A2 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens |
07/25/2012 | EP2478011A1 Fluorinated ghrh antagonists |
07/25/2012 | EP2478010A1 Partial peptide of lacritin |
07/25/2012 | EP2478009A1 Peptides for the treatment of oxidative stress related disorders |
07/25/2012 | EP2478003A1 Hair growth methods using fgfr4 extracellular domains |
07/25/2012 | EP2478002A2 Small peptide modulators of potassium channel trafficking |
07/25/2012 | EP2478001A2 Advantageous mu-opiate receptor peptide compounds |
07/25/2012 | EP2477657A1 Diagnostic and therapeutic uses of soluble fc-epsilon receptor i for ige-mediated disorders |
07/25/2012 | EP2477655A2 Vaccines directed to langerhans cells |
07/25/2012 | EP2477646A1 Use of arc for inhibiting cell death during liver failure |
07/25/2012 | EP2477645A1 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency |
07/25/2012 | EP2477644A1 Stable non-aqueous liquid pharmaceutical compositions comprising an insulin |
07/25/2012 | EP2477643A1 Long-acting y2 receptor agonists |
07/25/2012 | EP2477642A1 Method of treating asthma with antiviral agents |
07/25/2012 | EP2477641A2 Inhibition of endosomal toll-like receptor activation |
07/25/2012 | EP2477640A2 Methods of treating a patient receiving a cardiac stent implant |
07/25/2012 | EP2477612A2 Implant devices that differ by release profile and methods of making and using same |
07/25/2012 | EP2170400B1 Pharmaceutical liquid composition of botulinum toxin with improved stability |
07/25/2012 | EP2077266B1 2-pyridinecarboxamide derivative having gk-activating activity |
07/25/2012 | EP1858541B1 Use of bmp antagonists to regulate hepcidin-mediated iron metabolism and treat iron deficiency |
07/25/2012 | EP1751175B1 Interleukin-1 receptor antagonists, compositions, and methods of treatment |
07/25/2012 | EP1711531B9 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof |
07/25/2012 | EP1605897B1 Polyethelene glycol link glp-1 compounds |
07/25/2012 | EP1558276B1 Flaviviris fusion inhibitors |
07/25/2012 | EP1333808B1 Electroprocessed composition used in drug delivery and cell encapsulation |
07/25/2012 | EP1257544B1 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
07/25/2012 | EP1252162B1 Alpha v integrin receptor antagonists |
07/25/2012 | EP1080111B1 The induction of antiobiotic peptides by lait (scd14) protein |
07/25/2012 | EP0800829B2 Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin |
07/25/2012 | CN1872334B Slow releasing microsphere preparation of Thymopentin, and preparation method |
07/25/2012 | CN1653179B Cartilage regeneration using chondrocyte and TGF-beta |
07/25/2012 | CN1608078B Gonadotrophins for folliculogenesis |
07/25/2012 | CN102612558A Pcsk9疫苗 Pcsk9 vaccine |
07/25/2012 | CN102612373A Therapeutic agent for gastrointestinal diseases |
07/25/2012 | CN102612362A Controlled release formulations of lipocalin muteins |
07/25/2012 | CN102605030A Enzymatic extraction method for oat peptide |
07/25/2012 | CN102605029A Lactobacillus brevis bacteriocin and preparation method thereof |
07/25/2012 | CN102604970A Preparation method and application of medoggreenpit-viper venom L-amino acid oxidase |
07/25/2012 | CN102604960A Neurotoxin S10a of South China Sea Conus striatus, coding sequence and application of the neurotoxin |
07/25/2012 | CN102603897A Fusion protein containing guide peptide and GnRH-PE39KDEL as well as nucleic acid and application thereof |
07/25/2012 | CN102603887A IL-24 (interleukin-24) polypeptide with tumor resistance and application thereof |
07/25/2012 | CN102603886A Mutant fibroblast growth factor and use thereof in treating endocrine diseases |
07/25/2012 | CN102603885A Alexin and application thereof to preparation of antibacterial medicament |
07/25/2012 | CN102603884A Diamond back moth antibacterial peptide and preparation method and application thereof |
07/25/2012 | CN102603883A Antibacterial peptide, as well as preparation method and application thereof |
07/25/2012 | CN102603882A Antifungal peptide as well as preparation method and application thereof |
07/25/2012 | CN102603881A Anticoagulant active oligopeptide, and extraction and purification of anticoagulant active oligopeptide compound in Whitmania pigra |
07/25/2012 | CN102603871A Novel thiostrepton analog, as well as preparation method and application thereof |
07/25/2012 | CN102603868A Synthetic polypeptide and application of synthetic polypeptide |
07/25/2012 | CN102603865A Dipeptide derivative and application of the dipeptide derivative |
07/25/2012 | CN102600460A Application of proteolytic enzyme preparation in tumor treatment |
07/25/2012 | CN102600459A Usage of lactoferrin in prevention and treatment of tumor metastasis |
07/25/2012 | CN102600458A Compound preparation of glucosamine chondroitin and production method of compound preparation |
07/25/2012 | CN102600457A Compound propolis composition used for treating pig viral diarrhea and preparation method thereof |
07/25/2012 | CN102600456A Bioadhesive vaginal plug for treating vaginitis and cervicitis as well as preparation method of bioadhesive vaginal plug |
07/25/2012 | CN102600455A Remedy and therapeutic method for periodontal diseases and pulpal diseases |
07/25/2012 | CN102600454A Application of CD137L in preparation of medicine for treating non-small cell lung cancer |
07/25/2012 | CN102600453A Preparation method of colistin sulfate premixing agents |
07/25/2012 | CN102600452A Dipeptide derivative for improving liver function, and its application |
07/25/2012 | CN102600451A Felodipine ramipril compound sustained-release preparation and preparation method thereof |
07/25/2012 | CN102600450A Traditional Chinese preparation for treating depression |
07/25/2012 | CN102600203A Medicine composition for preventing or curing degenerative disease caused by oxidative stress |
07/25/2012 | CN102600076A Cyclosporine A solid self-microemulsion particle and preparation method thereof |
07/25/2012 | CN102600067A Preparation method of glycopeptide hydrogel containing glucosamine unit and application of glycopeptide hydrogel to preparing postoperation scar inhibitor |
07/25/2012 | CN102178926B Peptide for preventing or treating liver damage |
07/25/2012 | CN102154300B Conus lividus neurotoxin and coding sequence and use thereof |
07/25/2012 | CN102133200B Human relaxin-2 lyophilized powder preparation for injection |
07/25/2012 | CN102121010B Takifugu obscures B lymphocyte stimulating factor cDNA and cloning method and recombination application thereof |
07/25/2012 | CN102085360B Medical composition with raw materials containing hirudin and application thereof |
07/25/2012 | CN102078593B Application of toad peptide antibiotic for preparing medicines for curing diabetic foot |
07/25/2012 | CN102041238B Lactobacillus plantarum, method for fermenting and preparing bacteriocin of Lactobacillus plantarum, and application of Lactobacillus plantarum and bacteriocin |
07/25/2012 | CN102028937B SOD (Super Oxide Dlsmutase) medicament composition for resisting ageing, reducing blood pressure and blood fat and preparation method thereof |
07/25/2012 | CN101982197B Plukenetia volubilis polypeptide oral liquid |
07/25/2012 | CN101974395B Powerful antifatigue super oxide dismutase (SOD) health wine and preparation method thereof |
07/25/2012 | CN101953796B Method for preparing recombinant human endostatin chitosan nanoparticles for injection |
07/25/2012 | CN101934068B Preparation method of thymopetidum injection |
07/25/2012 | CN101921788B Meretrix lysozyme gene and coding protein and application thereof |